Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Lamiwel
Lamiwel (Lamivudine 100mg) is a potent antiviral medication belonging to the class of nucleoside reverse transcriptase inhibitors (NRTIs). It is widely used for the management of chronic hepatitis B and as part of combination therapy for HIV-1 infection. With proven efficacy in reducing viral replication, Lamiwel helps slow disease progression and lowers the risk of complications such as liver fibrosis and cirrhosis.
Uses of Lamiwel
Treatment of chronic hepatitis B to reduce viral load and liver damage
Part of combination antiretroviral therapy (ART) for HIV-1 infection
Prevention of hepatitis B reactivation in immunocompromised patients
Benefits of Lamiwel
Effectively suppresses hepatitis B virus (HBV) replication
Enhances immune function and slows liver disease progression
Well-tolerated with minimal side effects in long-term therapy
Oral formulation ensures easy administration and adherence
Mechanism of Action of Lamiwel
Lamiwel contains Lamivudine, which inhibits the reverse transcriptase enzyme essential for viral DNA replication. By incorporating into viral DNA, it causes chain termination, preventing the virus from multiplying. This leads to a significant reduction in viral load, helping manage chronic hepatitis B and HIV effectively.